Arizona 2024 Regular Session

Arizona Senate Bill SB1002

Introduced
1/8/24  

Caption

Drug paraphernalia; testing; analyzing; repeal

Impact

The revisions introduced by SB1002 are intended to clarify and potentially strengthen laws against the use and distribution of drug paraphernalia. By explicitly defining what constitutes drug paraphernalia and the circumstances under which individuals can be charged with felonies, the bill seeks to enhance law enforcement's ability to combat drug misuse. Notably, it maintains existing prohibitions while also aiming to make the legal framework more coherent, which may simplify prosecution for related offenses.

Summary

SB1002, introduced in the Arizona Senate, aims to amend Section 13-3415 of the Arizona Revised Statutes, specifically concerning drug paraphernalia. The bill focuses on regulating the possession, manufacture, delivery, and advertisement of items considered as drug paraphernalia, establishing that violations can result in class 6 felony charges. This legislation aligns with Arizona's ongoing efforts to address drug-related issues while balancing enforcement and individual rights.

Contention

While supporters argue that SB1002 will help mitigate drug abuse by deterring the sale and use of drug paraphernalia, critics may raise concerns about its implications for personal freedoms and potential overreach in criminalizing items that could have legitimate uses. The addition of forfeiture provisions also sparks debate about due process; opponents might argue that the broad nature of 'drug paraphernalia' could lead to the unjust seizure of personal property.

Companion Bills

No companion bills found.

Similar Bills

CA AB1598

Controlled substances: paraphernalia: controlled substance testing.

AZ SB1615

Drug paraphernalia; classification

AZ SB1400

Drug paraphernalia; testing; analyzing; repeal

AZ SB1159

Drug paraphernalia; testing; analyzing; repeal

CA AB2136

Controlled substances: analyzing and testing.

CA SB6

Controlled substances: xylazine.

CA SB1502

Controlled substances: xylazine.

CA AB3029

Controlled substances.